Routine Metabolic Laboratory Profile and Time-Stratified Machine-Learning Risk Stratification of Rosacea: A Combined Retrospective-Prospective Cohort Study.
- 1Department of Dermatology, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, People's Republic of China.
Abstract
Purpose
Rosacea has been linked with systemic metabolic abnormalities in case-control studies, but most such evidence compares rosacea patients with healthy controls rather than asking which patients within a rosacea population carry the greatest metabolic burden. We aimed to describe the metabolic profile of a real-world rosacea outpatient cohort and build a time-stratified, outcome-independent machine-learning model ranking which routine metabolic indicators predict metabolic syndrome status.Patients and methods
We conducted a combined retrospective-prospective study of 298 outpatients with rosacea, seen at a tertiary dermatology clinic from March 2021 to March 2026, contributing 5420 laboratory records (repeated measurements; 298 unique patients) across nine metabolic indicators. The outcome was metabolic syndrome status, defined with a modified NCEP-ATP III definition that includes fasting glucose, triglycerides, blood pressure and waist circumference (Laboratory Variables); fasting glucose and triglycerides were then excluded from the predictors; a random forest classifier was built from the remaining seven indicators, trained on patients enrolled in 2021-2022 (n=164) and evaluated on a time-stratified holdout enrolled in 2022-2023 (n=134). A subset of 83 patients with ≥2 follow-up visits was used to examine within-patient change over time.Results
Abnormal fasting glucose occurred in 23.7% of records and abnormal triglycerides in 31.4%. Patients with metabolic syndrome (n=64, 21.5%) had higher CRP (6.8±3.1 vs 2.4±1.6 mg/L, P<0.001) and higher severity scores (14.2±3.5 vs 10.1±3.0, P=0.003). On the holdout, the random forest model reached an AUC of 0.734 (95% CI 0.628-0.824), with CRP, total cholesterol, ALT, and HbA1c as leading contributors. Change in fasting glucose correlated with change in severity score on follow-up (ρ=0.31, P=0.004).Conclusion
Outpatients with rosacea frequently show systemic metabolic disturbances aligned with metabolic syndrome status and clinical severity. A machine-learning model built from routinely available, non-diagnostic indicators retained discrimination on a time-stratified holdout, suggesting a low-cost approach to flagging metabolic risk in this population, which requires external validation in independent, multicenter cohorts before clinical use.
Related
- A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study
- Development and validation of a ferroptosis and metabolic reprogramming gene signature for risk stratification in bladder urothelial carcinoma: A retrospective multicohort study.
- Association between neutrophil percentage-to-albumin ratio and all-cause mortality in stroke survivors stratified by triglyceride-glucose index : A prospective observational study based on the NHANES database from 1999 to 2018
- High Mortality in Adults With Community-Acquired Pneumonia Admitted to Hospitals in South Africa Before and During the COVID-19 Pandemic, Stratified by HIV Serostatus and Viral Load: Data From a Prospective Cohort Study (2019–2021)
- Prehabilitation and Early Recovery After Surgery (ERAS) in head and neck cancers: a protocol for a prospective, stratified, open-label randomised controlled trial in adults (PreERA)
BibTeX
@article{wu2026routine,
title = {{Routine Metabolic Laboratory Profile and Time-Stratified Machine-Learning Risk Stratification of Rosacea: A Combined Retrospective-Prospective Cohort Study.}},
author = {Meng Wu and Ke Li and Yangying Liao and Lan Li and Xiao Xiao and Junweichen Guo and Hao Feng},
journal = {Clinical, cosmetic and investigational dermatology},
year = {2026},
month = oct,
doi = {10.2147/ccid.s634954},
url = {https://europepmc.org/article/MED/42960137},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Routine Metabolic Laboratory Profile and Time-Stratified Machine-Learning Risk Stratification of Rosacea: A Combined Retrospective-Prospective Cohort Study.
AU - Meng Wu
AU - Ke Li
AU - Yangying Liao
AU - Lan Li
AU - Xiao Xiao
AU - Junweichen Guo
AU - Hao Feng
PY - 2026
DA - 2026/10/25
JO - Clinical, cosmetic and investigational dermatology
DO - 10.2147/ccid.s634954
UR - https://europepmc.org/article/MED/42960137
AB - Purpose Rosacea has been linked with systemic metabolic abnormalities in case-control studies, but most such evidence compares rosacea patients with healthy controls rather than asking which patients within a rosacea population carry the greatest metabolic burden. We aimed to describe the metabolic profile of a real-world rosacea outpatient cohort and build a time-stratified, outcome-independent machine-learning model ranking which routine metabolic indicators predict metabolic syndrome status.Patients and methods We conducted a combined retrospective-prospective study of 298 outpatients with rosacea, seen at a tertiary dermatology clinic from March 2021 to March 2026, contributing 5420 laboratory records (repeated measurements; 298 unique patients) across nine metabolic indicators. The outcome was metabolic syndrome status, defined with a modified NCEP-ATP III definition that includes fasting glucose, triglycerides, blood pressure and waist circumference (Laboratory Variables); fasting glucose and triglycerides were then excluded from the predictors; a random forest classifier was built from the remaining seven indicators, trained on patients enrolled in 2021-2022 (n=164) and evaluated on a time-stratified holdout enrolled in 2022-2023 (n=134). A subset of 83 patients with ≥2 follow-up visits was used to examine within-patient change over time.Results Abnormal fasting glucose occurred in 23.7% of records and abnormal triglycerides in 31.4%. Patients with metabolic syndrome (n=64, 21.5%) had higher CRP (6.8±3.1 vs 2.4±1.6 mg/L, P<0.001) and higher severity scores (14.2±3.5 vs 10.1±3.0, P=0.003). On the holdout, the random forest model reached an AUC of 0.734 (95% CI 0.628-0.824), with CRP, total cholesterol, ALT, and HbA1c as leading contributors. Change in fasting glucose correlated with change in severity score on follow-up (ρ=0.31, P=0.004).Conclusion Outpatients with rosacea frequently show systemic metabolic disturbances aligned with metabolic syndrome status and clinical severity. A machine-learning model built from routinely available, non-diagnostic indicators retained discrimination on a time-stratified holdout, suggesting a low-cost approach to flagging metabolic risk in this population, which requires external validation in independent, multicenter cohorts before clinical use.
SN - 1178-7015
ER -